Form 0920-0978 2017-18 FluSurv-NET Influenza Hospitalization Surveillan

Emerging Infections Program

11- 2017-18 FluSurv-NET Case Report Form

Influenza Hospitalization Surveilance Network Case Report Form

OMB: 0920-0978

Document [pdf]
Download: pdf | pdf
2017-18 FluSurv-NET Influenza Hospitalization
Surveillance Project Case Report Form

U.S. DEPARTMENT OF
HEALTH AND HUMAN SERVICES
CENTERS FOR DISEASE CONTROL
AND PREVENTION
ATLANTA, GA 30333

1

Case ID:

7

1

Form Approved
OMB No. 0920-0978

8
A. Patient Data – THIS INFORMATION IS NOT SENT TO CDC
First Name:

Last Name:
Address:

Middle Name:
Address Type:

(Number, Street, Apt. No.)
(City)

(State)

Phone No.2:

Chart No. :

Phone No. 1:

(Zip Code)

Emergency Contact:

Emergency Contact Phone:

No PCP

PCP Clinic Name 1:

PCP Phone 1:

PCP Fax 1:

PCP Clinic Name 2:

PCP Phone 2:

PCP Fax 2:

Site Use 2:

Site Use 1:

Site Use 3:

B. Abstractor Information – THIS INFORMATION IS NOT SENT TO CDC
1. Abstractor Name:

2. Date of Abstraction:
C. Enrollment Information

1. Case Classification:
Prospective Surveillance
6. Date of Birth:

/

Discharge Audit
7. Age:

Years

Hispanic or Latino

3. County:

(if < 1 month)

9. Race:

Male
Female

(if < 1 yr)

/

4. State:

5. Case Type:
Pediatric

Observation Only
8. Sex:

Days

Months

/

10. Ethnicity:

2. Admission Type:
Hospitalization

/

White
Black or African American
Asian/Pacific Islander

American Indian or Alaska Native
Multiracial
Not specified

12. Was patient discharged from any hospital within 1 week prior to the
current admission date?
Yes
No
Unknown

11. Hospital ID Where Patient Treated:

Non-Hispanic or Latino 11a. Admission Date:

/

/

13. Was patient transferred from another hospital?

Not Specified

/

/

13a. Transfer Hospital ID:

11b. Discharge Date:

Adult

14. Where did patient reside at the time of hospitalization? (Indicate TYPE of residence.)
Private residence
Hospice
Assisted living/Residential care
Homeless/Shelter
LTACH
Nursing home/Skilled Nursing Facility
Group home/Retirement
Alcohol/Drug Abuse Treatment
Mental Hospital
Hospitalized at birth
Unknown
Rehabilitation facility
Other long term care facility
Jail/Prison

/

15. Type of Insurance:

14a. If resident of a facility, indicate NAME of facility:

Unknown

/

/

(Check all that apply):

Private
Medicare
Medicaid/state assistance program
Military
Indian Health Service

Other, specify:

No

/

13b. Transfer Hospital Admission Date:
13c. Transfer Date:

Yes

Incarcerated
Uninsured
Unknown
Other, specify:

D. Influenza Testing Results (can add up to 4 test results in database)
1. Test 1:
1a. Result:

Rapid Antigen

Molecular Assay

/

1b. Specimen collection date:
2. Test 2:
2a. Result:

Rapid Antigen

3a. Result:

H1, Seasonal
H1
H3

Flu A (no subtype)
2009 H1N1
H1, Unspecified
Rapid Antigen

/

/

Molecular Assay
H1, Seasonal
H1
H3

Flu A (no subtype)
2009 H1N1
H1, Unspecified

3b. Specimen collection date:

/

Molecular Assay

2b. Specimen collection date:
3. Test 3:

H1, Seasonal
H1
H3

Flu A (no subtype)
2009 H1N1
H1, Unspecified

/

/

Rapid Molecular Assay
Flu A, Unsubtypable
Flu B (no lineage)
Flu B, Victoria

Viral Culture

Flu B, Yamagata
Flu A & B
Flu A/B (Not Distinguished)

1c. Testing facility ID:
Rapid Molecular Assay
Flu A, Unsubtypable
Flu B (no lineage)
Flu B, Victoria

Flu A, Unsubtypable
Flu B (no lineage)
Flu B, Victoria

Fluorescent Antibody
Unknown Type
Negative
H3N2v

Method Unknown
Other, specify:

1d. Specimen ID:
Viral Culture

Serology

Flu B, Yamagata
Flu A & B
Flu A/B (Not Distinguished)

2c. Testing facility ID:
Rapid Molecular Assay

Serology

Fluorescent Antibody
Unknown Type
Negative
H3N2v

Method Unknown
Other, specify:

2d. Specimen ID:
Viral Culture

Serology

Flu B, Yamagata
Flu A & B
Flu A/B (Not Distinguished)

3c. Testing facility ID:

Fluorescent Antibody
Unknown Type
Negative
H3N2v

Method Unknown
Other, specify:

3d. Specimen ID:

Public reporting burden of this collection of information is estimated to average 25 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the
collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB Control Number. Send comments regarding this burden estimate or any other aspect of this
collection of information, including suggestions for reducing this burden to CDC/ATSDR Information Collection Request Office, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0920-0978).

Page 1 of 4

2017-18 FluSurv-NET Influenza Hospitalization
Surveillance Project Case Report Form

1

Case ID:

7

1

8

E. Admission and Patient History

/

1. Date of onset of acute condition resulting in current hospitalization:

/

2. Acute signs/symptoms present at admission (began or worsened within 2 weeks prior to admission):
Non-respiratory symptoms
Fatigue/weakness
Fever/chills
Headache
Myalgia/muscle aches

Nausea/vomiting
Rash
Seizures
Other, non-respiratory

/

3. Date of onset of acute respiratory symptoms (within 2 weeks before a positive flu test):
6. Weight:

5. Height:

Unk

In

Cm

Lbs

Unk

Kg

Unk

7. Smoker (tobacco):
Former
Current

Opioids

Other, specify:
No/Unknown

11b. Chronic Lung Disease

Yes

No/Unknown

Yes

No/Unknown

Yes

No/Unknown

Yes

No/Unknown

Active Tuberculosis/TB
Cystic fibrosis
Emphysema/COPD
Chronic bronchitis
Chronic respiratory failure
Other, specify:
11c. Chronic Metabolic Disease
Diabetes Mellitus
Thyroid dysfunction
Other, specify:
11d. Blood disorders/Hemoglobinopathy
Aplastic anemia
Sickle cell disease
Splenectomy/Asplenia
Other, specify:
11e. Cardiovascular Disease

Aortic aneurysm
Aortic stenosis
Atrial Fibrillation
Cardiomyopathy
Atherosclerotic cardiovascular disease (ASCVD)
Cerebral vascular incident/Stroke
Congenital heart disease
Coronary artery disease (CAD)
Ischemic cardiomyopathy
Non-ischemic cardiomyopathy
Heart failure/CHF
Other, specify:
11f. Neuromuscular disorder
Duchenne muscular dystrophy
Muscular dystrophy
Multiple sclerosis
Mitochondrial disorder
Myasthenia gravis
Parkinson’s disease
Other, specify:
11g. Neurologic disorder

Yes

Yes

Unknown

8. Alcohol abuse:
Current

(check all that apply):

11. Did patient have any of the following pre-existing medical conditions? Check all that apply.
Yes

/

Yes

No

Marijuana

Current

Former

No/Unk
Yes

No/Unknown

E-cigarettes

Other

Unknown

11h History of Guillain-Barré Syndrome

Yes
No/Unknown
11i. Immunocompromised Condition
Yes
No/Unknown
AIDS or CD4 count < 200
Cancer: current/in treatment or diagnosed in last 12 months
Complement deficiency
HIV Infection
Immunoglobulin deficiency
Immunosuppressive therapy
Organ transplant
Stem cell transplant (e.g., bone marrow transplant)
Steroid therapy (taken within 2 weeks of admission)
Other, specify:

11j. Renal Disease
Yes
No/Unknown
Chronic kidney disease/chronic renal insufficiency
End stage renal disease/Dialysis
Glomerulonephritis
Nephrotic syndrome
Other, specify:
11k. Liver disease
Yes
No/Unknown
Cirrhosis
Viral hepatitis (B or C)
Other, specify:
11l. Any obesity
Obese
Morbidly obese (ADULTS ONLY)
11m. Pregnant

No/Unknown

Not applicable

9. Substance abuse:

Former

(Optional) 10. Current Non-Tobacco Smoker:
Unknown

11a. Asthma/Reactive Airway Disease

Congested/runny nose
URI/ILI
Cough
Wheezing
Shortness of breath/respiratory distress
Sore throat

No/Unk

No/Unk

9a. Substance Abuse Type (current use only) (check all that apply):
IVDU

No Signs/Symptoms
Respiratory symptoms

Altered mental status/confusion
Chest pain
Conjunctivitis/pink eye
Diarrhea

4. BMI:

Unknown

Yes

No/Unknown

Yes
If pregnant, specify gestational age in weeks:
Unknown gestational age
11n. Post-partum (two weeks or less)
Yes
11o. Other
Yes
Systemic lupus erythematosus/SLE/Lupus
Other, specify:

No/Unknown

No/Unknown
No/Unknown

11p. PEDIATRIC CASES ONLY
Yes
No/Unknown
Abnormality of upper airway
Yes
No/Unknown
History of febrile seizures
Yes
No/Unknown
Long-term aspirin therapy
Yes
No/Unknown
Premature
(gestation age < 37 weeks at birth for patients < 2yrs)
If yes, specify gestational age at birth in weeks:
Unknown gestational age at birth

No/Unknown

Cerebral palsy
Cognitive dysfunction
Dementia/Alzheimer’s disease
Developmental delay
Down syndrome
Plegias/Paralysis
Seizure/Seizure disorder
Other, specify:
Page 2 of 4

2017-18 FluSurv-NET Influenza Hospitalization
Surveillance Project Case Report Form

1

Case ID:

7

1

8

F. Intensive Care Unit and Interventions (can record up to 3 ICU stays in database)
1. Was the patient admitted to an intensive care unit (ICU)?
1a. Number of ICU Admissions:

Yes

No

Unknown

2. Did patient receive invasive mechanical ventilation?
3. Did patient receive extracorporeal membrane oxygenation
(ECMO or ‘on bypass’)?

Yes

Unknown

1b. Date of first ICU Admission:

/

/

Unknown

1c. Date of first ICU Discharge:

/

/

Unknown

Yes

No

Unknown

No

Unknown

G. Bacterial Pathogens – Sterile or respiratory site only (can record up to 5 pathogens in database)
1. Were any bacterial culture tests performed with a collection date within three days of admission?

Yes

No

Unknown

2. If yes, was there a positive culture for a bacterial pathogen?

Yes

No

Unknown

3a. If yes, specify Pathogen 1:

/

3b. Date of culture:

3c. Site where pathogen identified:
Blood
Bronchoalveolar lavage (BAL)
Pleural fluid
Other, specify:

/

3d. If Staphylococcus aureus, specify:

Methicillin resistant (MRSA)

4a. If yes, specify Pathogen 2:

Sensitivity unknown

4c. Site where pathogen identified:

/

4b. Date of culture:

Methicillin sensitive (MSSA)

Cerebrospinal fluid (CSF)
Sputum
Endotracheal aspirate

Blood
Bronchoalveolar lavage (BAL)
Pleural fluid
Other, specify:

/

4d. If Staphylococcus aureus, specify:

Methicillin resistant (MRSA)

Methicillin sensitive (MSSA)

Cerebrospinal fluid (CSF)
Sputum
Endotracheal aspirate

Sensitivity unknown

H. Viral Pathogens
1. Was patient tested for any of the following viral respiratory pathogens within 3 days of admission?

Yes

No

1a. Respiratory syncytial virus/RSV

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1b. Adenovirus

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1c. Parainfluenza 1

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1d. Parainfluenza 2

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1e. Parainfluenza 3

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1f. Parainfluenza 4

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1g. Human metapneumovirus

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1h. Rhinovirus/Enterovirus

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1i. Coronavirus (type):

Yes, positive

Yes, negative

Not tested/Unknown

Date:

Unknown

/
/
/
/
/
/
/
/
/

/
/
/
/
/
/
/
/
/

I. Influenza Treatment (can record up to 4 treatments in database)
1. Did patient receive antiviral medication treatment for influenza during the course of this illness?
2a. Treatment 1:

Oseltamivir (Tamiflu)
Peramivir (Rapivab)

2b. Method of Administration:
2c. Start Date:

/

Start Date Unknown
3a. Treatment 2:

/

Start Date Unknown
4a. Treatment 3:

Oral

/

Oseltamivir (Tamiflu)
Peramivir (Rapivab)

4b. Method of Administration:
4c. Start Date:

/

Oseltamivir (Tamiflu)
Peramivir (Rapivab)

3b. Method of Administration:
3c. Start Date:

Oral

/

Start Date Unknown

Oral

/

Zanamivir (Relenza)
Other, specify:
Intravenous (IV)

Unknown

Inhaled

/

End Date Unknown
Zanamivir (Relenza)
Other, specify:
Intravenous (IV)

/

End Date Unknown
Zanamivir (Relenza)
Other, specify:
Intravenous (IV)
4d. End Date:

/

End Date Unknown

75 mg

60 mg

QD

QOD

30 mg

3 mg/kg/dose

BID

45 mg

Dose Unknown

Frequency
Unknown

3f. Frequency:

75 mg

60 mg

QD

QOD

30 mg

3 mg/kg/dose

BID

45 mg

Dose Unknown

Frequency
Unknown

/

5. Additional Treatment Comments:

Page 3 of 4

TID
Other

4e. Dose:

Unknown

TID
Other

Other
Unknown

Inhaled

2f. Frequency:

3e. Dose:

Unknown

/

3d. End Date:

Unknown

Other
Unknown

Inhaled

No

2e. Dose:

Unknown

/

2d. End Date:

Yes

4f. Frequency:

75 mg

60 mg

QD

QOD

30 mg

3 mg/kg/dose

BID

45 mg

Dose Unknown

Frequency
Unknown

Other

TID
Other

2017-18 FluSurv-NET Influenza Hospitalization
Surveillance Project Case Report Form

1

Case ID:

7

1

8

J. Chest Radiograph – Based on radiology report only
1. Was a chest x-ray taken within 3 days of admission?
2. Were any of these chest x-rays abnormal?
Yes

No

No

Unknown

2b. For first abnormal chest x-ray, please check all that apply:
Report not available
Air space density
Air space opacity
Bronchopneumonia/pneumonia

Unknown

2a. Date of first abnormal chest x-ray:

/

Yes

/

Cannot rule out pneumonia
Consolidation
Cavitation
ARDS (acute respiratory distress syndrome)

Lung infiltrate
Interstitial infiltrate
Lobar infiltrate
Other

K. Discharge Summary

1. Did the patient have any of the following new diagnoses at discharge? (check all that apply)

No discharge summary available

Bacteremia
Yes
No/Unk
Acute encephalopathy/encephalitis
Yes
No/Unk
Reyes syndrome
Yes
Bronchiolitis
Yes
No/Unk
Acute Myocardial Infarction
Yes
No/Unk
Rhabdomyolysis
Yes
Congestive Heart Failure
Yes
No/Unk
Acute Myocarditis
Yes
No/Unk
Pneumonia
Yes
Sepsis
Yes
COPD exacerbation
Yes
No/Unk
Acute Renal Failure/Acute Kidney Injury
Yes
No/Unk
Seizures
Yes
Diabetic Ketoacidosis
Yes
No/Unk
Acute respiratory distress syndrome (ARDS)
Yes
No/Unk
Stroke
(CVA)
Yes
Guillan-Barre
syndrome
Yes
No/Unk
Acute respiratory failure
Yes
No/Unk
Hemophagocytic syndrome
Yes
No/Unk
Asthma exacerbation
Yes
No/Unk
2. What was the outcome
2a. If discharged alive, please indicate to where:
of the patient?
Private residence
Rehabilitation Facility
Group home/Retirement home
Homeless/Shelter
Jail/Prison
Mental Hospital
Alive
Deceased
Nursing home /Skilled Nursing Facility
Hospice
Unknown
Unknown
Alcohol/Drug Abuse Treatment
Assisted living/Residential care
Other, specify:
Home with services
LTACH
3. If patient was pregnant on admission, indicate pregnancy status at discharge:
Still pregnant
No longer pregnant
Unknown

No/Unk
No/Unk
No/Unk
No/Unk
No/Unk
No/Unk

3a. If patient was pregnant on admission but no longer pregnant at discharge, indicate pregnancy outcome at discharge:
Miscarriage
Ill newborn
Newborn died
Healthy newborn
Abortion
Unknown
4. Additional notes regarding discharge:

L. ICD-10 Discharge Diagnoses – To be recorded in order of appearance

ICD codes
not available

1.

4.

7.

2.

5.

8.

3.

6.

9.
M. Vaccination History

Specify vaccination status and date(s) by source:
1. Medical Chart:

Yes, full date known

1a. If yes, specify dosage date information:
1b. If patient < 9 yrs, specify vaccine type:

/

/

Injected Vaccine

2.Vaccine Registry:

Yes, full date known
2a. If yes, specify dosage date information:
/

2b. If patient < 9 yrs, specify vaccine type:

Injected Vaccine

3. Primary Care Provider /LTCF:

Yes, full date known
3a. If yes, specify dosage date information:
/

3b. If patient < 9 yrs, specify vaccine type:

Injected Vaccine

4. Interview:

Yes, full date known
Patient
Proxy
4a. If yes, specify dosage date information:
/
4b. If patient < 9 yrs, specify vaccine type:

Yes, specific date unknown

Injected Vaccine

No

Date Unknown
Combination of both

Nasal Spray/FluMist
Yes, specific date unknown

/

No

Yes, specific date unknown

/

No

Yes, specific date unknown

No

6. If patient < 9 yrs, did patient receive 2

influenza vaccine in current season?

6a. If yes, specify 2 dosage date information:
nd

/

Yes

/

Unknown

Date Unknown
Combination of both

5. If patient < 9 yrs, did patient receive any seasonal influenza vaccine in previous seasons?
nd

Unknown

Date Unknown
Combination of both

Nasal Spray/FluMist

/

Unknown

Date Unknown
Combination of both

Nasal Spray/FluMist

Nasal Spray/FluMist

Unknown

Yes
No

No

Not Checked

Unsuccessful Attempt

Unknown type
Not Checked

Unsuccessful Attempt

Unknown type
Not Checked

Unsuccessful Attempt

Unknown type
Not Checked

Unsuccessful Attempt

Unknown type
Unknown

Unknown
Date Unknown

N. Miscellaneous
1. Additional Comments:

CDC Rev. 07-2017

Page 4 of 4

CS279597


File Typeapplication/pdf
File Modified2017-11-17
File Created2017-08-04

© 2024 OMB.report | Privacy Policy